Medbox Inc (OTCMKTS:MDBX) Moves Up On News

[[tagnumber 0]][[tagnumber 1]]After an upward rush in the end of August we saw the stock of Medbox Inc (OTCMKTS:MDBX) slide down the charts and lost quite a lot of the value it had gained, while the daily volumes became rather low.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Last month we saw the ticker slide below the 10 cent per share mark and trading increased subsequently. Earlier this month we saw the company stock attempt an upward run, but the hype was short–lived and [[tagnumber 6]]MDBX[[tagnumber 7]] lost the gains fairly quick. This comes as no excitement after you take a quick look at the numbers contained in the most recent financial filing of the company.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $564 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $1.65 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $13.16 million[[tagnumber 13]] [[tagnumber 12]]quarterly revenues: $84 thousand[[tagnumber 13]] [[tagnumber 12]]quarterly net loss: $11.39 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Although the company’s cash positions are rather decent and it has started generating revenues we see that the liabilities and the net loss are simply massive. Still, [[tagnumber 6]]MDBX[[tagnumber 7]] has a rather small market cap when compared to other OTC entities with far less to show.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]That, however, didn’t stop the ticker from starting this week on a bad note, losing 8.40% in Monday’s trading. After the company announced that it has received a license approval and has signed an agreement with a farmer for cultivating hemp in Colorado yesterday we saw the ticker make a turn and gain 11.84% and close the session with a price of $0.0671.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]It seems like the hype from the news, however, will be short–lived once again as the ticker is already trading in the red as of the writing of this article. Be sure to do your due diligence and weigh out the risks before putting any money on the line. [[tagnumber 2]]